Masimo Corporation
NASDAQ:MASIMedical - Devices
+$0.00 today
- Market cap
- $9.42B
- Beta
- 1.10
- P/E (TTM)
- 123.1
- EPS (TTM)
- $1.46
Volume 0.00M
Average 1.08M
MASI Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Masimo CorporationNASDAQ: MASI
Stock-Based Compensation · Q1 FY2026 · quarter ended Apr 2026
Stock-based compensation declines year over year
Q1 FY2026 stock-based compensation of $8.9M fell 2.2% year over year, ahead of the -37.2% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -9.1% a year.
Context
- Stock-based compensation amounted to 2.3% of revenue in FY2025, up 0.4 pp from a year earlier.
- Stock-based compensation increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -2.2% holds above the trailing-twelve-month pace of -37.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 35.8M USD
- Year-over-year change
- -13.7%
- 4-year CAGR
- -5.4%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 35.8M | -13.7% |
| FY2024 | 2024-12-28 | 41.5M | +492.9% |
| FY2023 | 2023-12-31 | 7M | -85.3% |
| FY2022 | 2022-12-31 | 47.7M | +6.7% |
| FY2021 | 2021-12-31 | 44.7M | — |
Stock-Based Compensation vs competitors
How MASI compares with its peers on the latest reported figures
- Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -37.2% is the 9th highest of 10, against a peer median of -13.7%.
- Stock-based compensation amounts to 1.7% of revenue for MASI, versus a peer median of 1.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $115M USD | -5.7% | -5.8% | 1.0% | |
| LTM Sep 2026 | $105M USD | +133.3% | -23.0% | 0.2% | |
| LTM Sep 2026 | $93.45M USD | +60.8% | +49.9% | 33.3% | |
| LTM Jun 2026 | $45.8M USD | +43.1% | -1.6% | 1.8% | |
| LTM Jun 2026 | $42.5M USD | -16.5% | +0.4% | 0.6% | |
| LTM Jun 2026 | $40.84M USD | -13.7% | — | 1.0% | |
| LTM Jun 2026 | $33.29M USD | -26.1% | +6.1% | 4.2% | |
| LTM Jun 2026 | $29M USD | -17.1% | — | 0.2% | |
| LTM Apr 2026 | $26.3M USD | -37.2% | -9.1% | 1.7% | |
| FY2025 | €0 EUR | -100.0% | — | — | |
| LTM Jun 2026 | €0 EUR | — | — | 0.0% | |
| Peer median (excluding MASI) | — | -13.7% | -0.6% | 1.0% | |
Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 229.6M | 143.5M | 81.5M | (304.9M) | (151.5M) |
| Depreciation & Amortization | 35.6M | 136.1M | 98.3M | 103M | 38.8M |
| Deferred Income Tax | (15.1M) | (39.3M) | (35.6M) | (38.2M) | 11.8M |
| Stock-Based Compensation | 44.7M | 47.7M | 7M | 41.5M | 35.8M |
| Change in Working Capital | (31.5M) | (261.8M) | (70.9M) | (10.7M) | (89.9M) |
| Accounts Receivables | (76.9M) | (151.3M) | 91.9M | (60.2M) | 17.2M |
| Inventory | 13.5M | (155.9M) | (69.2M) | (7.5M) | (112.1M) |
| Accounts Payables | 11M | 60.5M | (19.6M) | 14.8M | (27.1M) |
| Other Working Capital | 20.9M | (15.1M) | (74M) | 42.2M | 32.1M |
| Other Non-Cash Items | 1.3M | 3.2M | 13.8M | 405.7M | 372.2M |
| Operating Cash Flow | 264.6M | 29.4M | 94.1M | 196.4M | 217.2M |
| Capital Expenditures | (34.9M) | (56.3M) | (87.7M) | (51.1M) | (19.4M) |
| Acquisitions (Net) | 0 | (999.7M) | 7.5M | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (12M) | (5.2M) | (44.7M) | (31.2M) | 294.5M |
| Investing Cash Flow | (37.5M) | (1.06B) | (81.2M) | (51.2M) | 275.1M |
| Debt Repayment | 0 | 939.2M | (51.2M) | (146.8M) | (207.8M) |
| Common Stock Issued | 23.2M | 8.1M | 7M | 25.2M | 71.4M |
| Common Stock Repurchased | (128.9M) | (401.5M) | 0 | 0 | (363.7M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (16.7M) | (25.4M) | (12.9M) | (4M) | (20.6M) |
| Financing Cash Flow | (122.4M) | 520.4M | (57.1M) | (125.6M) | (520.7M) |
| Effect of Forex Changes | (1.3M) | (30.9M) | 2.8M | (6.4M) | 53.8M |
| Net Change in Cash | 103.4M | (538.8M) | (41.4M) | 13.2M | 26M |
| Free Cash Flow | 229.7M | (26.9M) | 6.4M | 145.3M | 197.8M |
Masimo Corporation
NASDAQ:MASI
Intrinsic Alpha fair value
Locked
Current Price
$179.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.